Amundi Medifast Inc Transaction History

Amundi

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$97.09 - $130.31 $128,255 - $172,139	1,321 Added 234.64%	1,884 $195,000
Q4 2022 Feb 14, 2023	SELL	$103.38 - $126.05 $13,129 - $16,008	-127 Reduced 18.41%	563 $64,000
Q3 2022 Nov 14, 2022	BUY	$108.36 - $187.67 $48,653 - $84,263	449 Added 186.31%	690 $78,000
Q1 2022 May 16, 2022	SELL	$163.59 - $219.02 $498,295 - $667,134	-3,046 Reduced 92.67%	241 $41,000
Q4 2021 Feb 14, 2022	SELL	$185.81 - $230.36 $3.96 Million - $4.91 Million	-21,304 Reduced 86.63%	3,287 $667,000
Q3 2021 Nov 15, 2021	SELL	$192.64 - $288.27 $2.59 Million - $3.87 Million	-13,419 Reduced 35.3%	24,591 $4.74 Million
Q2 2021 Aug 16, 2021	BUY	$217.95 - $332.25 $8.28 Million - $12.6 Million	38,010 New	38,010 $10.8 Million

169

10.1M

542K

545K

Ticker MED
Exchange NYSE
Sector Consumer Cyclical
Industry Personal Services
Shares Outstandng 11,017,900
Market Cap $214M
Description
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.